Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
6.57
-0.02 (-0.30%)
Aug 26, 2026, 12:58 PM EDT - Market open

Prelude Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-60.49-99.5-127.17-121.83-115.44-111.69
Depreciation & Amortization
1.591.711.771.171.320.92
Loss (Gain) From Sale of Investments
-0.94-0.37-4.64-3.472.591.36
Stock-Based Compensation
8.2911.9121.3525.6225.1420.93
Other Operating Activities
1.541.531.591.941.721.33
Change in Accounts Payable
-3.19-3.923.31-2.27-0.353.9
Change in Unearned Revenue
25.2535.53----
Change in Other Net Operating Assets
-5.31-3.210.91-8.211.28-0.28
Operating Cash Flow
-33.26-56.3-102.89-107.06-83.73-83.53
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.07-0.76-3.51-3.02-2.32
Investment in Securities
-77.2553.5390.96-31.1384.71-261.48
Investing Cash Flow
-77.2553.4690.19-34.6581.69-263.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.21-0.4---
Net Debt Issued (Repaid)
--0.21-0.4---
Issuance of Common Stock
115.1825.040.44136.410.82165.2
Repurchase of Common Stock
-0.07-0.02-0.05-0.02--
Other Financing Activities
-4.66--0.11---0.3
Financing Cash Flow
110.4524.82-0.12136.40.82164.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.0621.97-12.82-5.31-1.22-182.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-33.26-56.37-103.65-110.58-86.75-85.85
Free Cash Flow Growth
------
Free Cash Flow Margin
-148.30%-464.32%-1480.74%---
Free Cash Flow Per Share
-0.40-0.73-1.37-1.83-1.83-1.86
Levered Free Cash Flow
-13.84-23.87-62-58.93-50.12-46.86
Unlevered Free Cash Flow
-13.84-23.87-62-58.93-50.12-46.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
16.7528.414.22-10.480.933.63
SEC Filings: 10-K · 10-Q